Surgery Doctors in Concord, MA Accepting Medicare

12 Surgery doctors found. Showing 1 - 12

Atif Khan, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 131 Old Road Nine Acre Corner, Jcb Suite 500, Concord, MA 01742 Phone: 978-287-3547    Fax: 978-287-2949

Frederick W. Hays M.d., Surgery Medicare: Not Enrolled in Medicare Practice Location: 290 Baker Ave, Concord, MA 01742 Phone: 978-369-5677    Fax: 978-371-1673

Dr. Nathan Paul Narasimhan, M.D. Surgery - Plastic and Reconstructive Surgery Medicare: Accepting Medicare Assignments Practice Location: 131 Ornac, John Cuming Building Ste 700, Concord, MA 01742 Phone: 978-369-4499    Fax: 866-743-7213

Seymour A Dimare, MD Surgery Medicare: Not Enrolled in Medicare Practice Location: 133 Ornac, Emerson Hospital, Concord, MA 01742 Phone: 978-369-1400

Dr. Brian Terence Callahan Jr., M.D. Surgery Medicare: Not Enrolled in Medicare Practice Location: 131 Ornac, Concord, MA 01742 Phone: 978-287-3547

C William Kaiser, M.D. Surgery Medicare: Not Enrolled in Medicare Practice Location: 8 Middle St, Concord, MA 01742 Phone: 508-662-3465

Laura Michelle Doyon, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 54 Baker Avenue Ext, Suite 101, Concord, MA 01742 Phone: 978-287-3532    Fax: 978-287-2902

Dr. Jane I-chen Tsao, M.D. Surgery Medicare: Not Enrolled in Medicare Practice Location: 1 Wright Farm, Concord, MA 01742 Phone: 978-287-4505    Fax: 978-287-4505

Susan L Cahill, M.D. Surgery Medicare: Not Enrolled in Medicare Practice Location: 131 Ornac, Suite 770, Concord, MA 01742 Phone: 978-369-4468    Fax: 978-369-4213

Andrea Resciniti, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 131 Ornac, Suite 435, Concord, MA 01742 Phone: 978-371-7433    Fax: 978-371-7431

Steven F Margolis, M.D. Surgery Medicare: Not Enrolled in Medicare Practice Location: 242 Baker Ave, Suite 306, Concord, MA 01742 Phone: 978-369-6762

Dr. Paul David Costas, MD Surgery - Plastic and Reconstructive Surgery Medicare: Accepting Medicare Assignments Practice Location: 131 Ornac, John Cuming Bldg Ste 850, Concord, MA 01742 Phone: 978-369-1579    Fax: 978-369-0304

News Archive

CTRC commences patient enrolment in Phase 2 clinical trial of REOLYSIN for metastatic melanoma

Oncolytics Biotech Inc. announced today that the Cancer Therapy Research Center at the University of Texas Health Science Center (CTRC) has started patient enrolment in a U.S. Phase 2 clinical trial using intravenous administration of REOLYSIN(R) in combination with paclitaxel and carboplatin in patients with metastatic melanoma.

Withdrawal of aid from Madagascar hitting poor hard

The Guardian's "Poverty Matters Blog" examines the effects of the withdrawal of international aid and debt relief from Madagascar following the country's last coup in 2009. According to the article, "80% of the population is classed as living in poverty. A household survey last year by the United Nations Children's Fund (Unicef) found that aid sanctions are biting the wrong people: school enrolment has plummeted and health indicators are in decline."

Urocortin 2 improves cardiac output in Phase II study for acute decompensated heart failure

Neurocrine Biosciences, Inc. today announced efficacy and safety results from a Phase II trial of urocortin 2 in 53 patients with acute decompensated heart failure. The UNICORN study was conducted over approximately a two year period by the Cardioendocrine Research Group from the University of Otago in Christchurch, New Zealand and included patients admitted to Christchurch Hospital with acute decompensated heart failure.

New book presents latest research on neuroendocrine physiology

In this volume an international group of basic and clinical investigators presents their latest research on neuroendocrine physiology, advances in the control of the onset of puberty and its disorders, and basic and clinical aspects of the GH/IGF-1 and hypothalamic-pituitary-adrenal axes. An entire section is dedicated to pituitary tumors, including genetics and neuroimaging, and another covers the neuroendocrine control of substrate metabolism, including hypothalamic obesity and anorexia.

ALS patients with commonly inherited genetic variation may experience more severe symptoms

A discovery made several years ago in a lab researching asthma at Wake Forest School of Medicine may now have implications for the treatment of amyotrophic lateral sclerosis (ALS), a disease with no known cure and only two FDA-approved drugs to treat its progression and severity.

Read more Medical News

› Verified 9 days ago